Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Annals of Pharmacotherapy
|
May 1, 1994
Patient care issues: the management of paclitaxel-related toxicities
R S Finley, E K Rowinsky
Drug Intelligence & Clinical Pharmacy
|
January 1, 1985
Combination antiemetic therapy in the control of chemotherapy-induced emesis
C L Fortner, R S Finley, W R Grove
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
June 26, 1998
Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents
J A Trovato, D M Stull, R S Finley
Drug Intelligence & Clinical Pharmacy
|
May 1, 1985
Cisplatin nephrotoxicity: a summary of preventative interventions
R S Finley, C L Fortner, W R Grove
Pharmacotherapy
|
November 1, 1982
Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions
C L Fortner, R S Finley, S C Schimpff
Clinical Pharmacy
|
July 1, 1982
Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonization
R S Finley, S C Schimpff, C L Fortner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1993
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients
J H Joshi, K A Newman, B W Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1983
Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung
C A de Jongh, J C Wade, R S Finley, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients
R S Finley, C L Fortner, C A deJongh, et al.
The American Journal of Medicine
|
June 26, 1987
Norfloxacin for prevention of bacterial infections in granulocytopenic patients
D J Winston, W G Ho, R E Champlin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Annals of Pharmacotherapy
|
May 1, 1994
Patient care issues: the management of paclitaxel-related toxicities
R S Finley, E K Rowinsky
Drug Intelligence & Clinical Pharmacy
|
January 1, 1985
Combination antiemetic therapy in the control of chemotherapy-induced emesis
C L Fortner, R S Finley, W R Grove
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
June 26, 1998
Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents
J A Trovato, D M Stull, R S Finley
Drug Intelligence & Clinical Pharmacy
|
May 1, 1985
Cisplatin nephrotoxicity: a summary of preventative interventions
R S Finley, C L Fortner, W R Grove
Pharmacotherapy
|
November 1, 1982
Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions
C L Fortner, R S Finley, S C Schimpff
Clinical Pharmacy
|
July 1, 1982
Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonization
R S Finley, S C Schimpff, C L Fortner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1993
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients
J H Joshi, K A Newman, B W Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1983
Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung
C A de Jongh, J C Wade, R S Finley, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients
R S Finley, C L Fortner, C A deJongh, et al.
The American Journal of Medicine
|
June 26, 1987
Norfloxacin for prevention of bacterial infections in granulocytopenic patients
D J Winston, W G Ho, R E Champlin, et al.
Page
of 3